Dr. Markley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Pump Rd
Richmond, VA 23233Phone+1 804-740-1100Fax+1 804-740-1055
Education & Training
- Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 2011 - 2014
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2008 - 2011
- Medical College of Georgia at Augusta UniversityClass of 2008
Certifications & Licensure
- VA State Medical License 2008 - 2026
- TN State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis Start of enrollment: 2022 Jun 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Effect of colchicine on 90-day outcomes in patients with acute myocarditis: a real-world analysis.Michele Golino, Alexa Coe, Anas Aljabi, Azita H Talasaz, Benjamin Van Tassell
American Heart Journal Plus. 2024-11-01 - Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, doubl...Antonio Abbate, Benjamin Van Tassell, Vlad Bogin, Roshanak Markley, Dmitry V Pevzner
Journal of Cardiovascular Pharmacology. 2024-10-02 - 1 citationsResults of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segmen...Antonio Abbate, Benjamin Van Tassell, Vlad Bogin, Roshanak Markley, Dmitry V Pevzner
Circulation. 2024-08-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: